These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 10976084)
21. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265 [TBL] [Abstract][Full Text] [Related]
22. Retinopathy in systemic lupus erythematosus: relationship to disease activity. Klinkhoff AV; Beattie CW; Chalmers A Arthritis Rheum; 1986 Sep; 29(9):1152-6. PubMed ID: 3753541 [TBL] [Abstract][Full Text] [Related]
23. Systemic risk factors of retinopathy in patients with systemic lupus erythematosus. Meng L; Yu Q; Zhao X; Chen L; Yang J; Wang Y; Chen H; Chen Y Acta Ophthalmol; 2024 Aug; 102(5):e774-e788. PubMed ID: 38396344 [TBL] [Abstract][Full Text] [Related]
24. Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement? Bashiri H; Karimi N; Mostafaei S; Baghdadi A; Nejadhosseinian M; Faezi ST BMC Rheumatol; 2021 Oct; 5(1):34. PubMed ID: 34593048 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the incidence of discoid lupus erythematosus in patients with systemic lupus erythematosus and its relationship to disease activity. Saghafi M; Hashemzadeh K; Sedighi S; Yazdanpanah MJ; Rezaieyazdi Z; Sahebari M; Esmaily H J Cutan Med Surg; 2014 Oct; 18(5):316-9. PubMed ID: 25186992 [TBL] [Abstract][Full Text] [Related]
26. SLE retinopathy: evaluation by fluorescein angiography. Lanham JG; Barrie T; Kohner EM; Hughes GR Ann Rheum Dis; 1982 Oct; 41(5):473-8. PubMed ID: 7125716 [TBL] [Abstract][Full Text] [Related]
27. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW; Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628 [TBL] [Abstract][Full Text] [Related]
28. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus. Sahin S; Adrovic A; Barut K; Durmus S; Gelisgen R; Uzun H; Kasapcopur O Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068 [TBL] [Abstract][Full Text] [Related]
30. A Comparitive Study of Anticardiolipin Antibodies among Systemic Lupus Erythematosus Patients from Western and Eastern India. Doley D; Kakati S; Saikia L; Rajadhyaksha A; Nadkar M; Khadilkar P; Patwardhan M; Pradhan V J Assoc Physicians India; 2017 Mar; 65(3):14-19. PubMed ID: 28462538 [TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
32. Immune-complex deposition in the eye in systemic lupus erythematosus. Aronson AJ; Ordoñez NG; Diddie KR; Ernest JT Arch Intern Med; 1979 Nov; 139(11):1312-3. PubMed ID: 159674 [TBL] [Abstract][Full Text] [Related]
33. Ocular fundus changes and association with systemic conditions in systemic lupus erythematosus. Meng L; Wang Y; Yang Z; Lin S; Wang Y; Chen H; Zhao X; Chen Y Front Immunol; 2024; 15():1395609. PubMed ID: 39091490 [TBL] [Abstract][Full Text] [Related]
34. Posterior segment involvement in systemic lupus erythematosus - A series from South India. Babu K; Nanda S; Hegde P; Rao AP; Jois R Indian J Ophthalmol; 2023 May; 71(5):1986-1993. PubMed ID: 37203070 [TBL] [Abstract][Full Text] [Related]
35. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
36. Paediatric-onset systemic lupus erythematosus. Malattia C; Martini A Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):351-62. PubMed ID: 24238692 [TBL] [Abstract][Full Text] [Related]
37. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus? Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236 [TBL] [Abstract][Full Text] [Related]
38. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus. Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230 [TBL] [Abstract][Full Text] [Related]
39. β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus. Wang CY; Chyuan IT; Wang YL; Kuo MY; Chang CW; Wu KJ; Hsu PN; Nagasawa T; Wara-aswapati N; Chen YW J Periodontol; 2015 Aug; 86(8):995-1004. PubMed ID: 25817824 [TBL] [Abstract][Full Text] [Related]
40. Retinal vasculopathy in patients with systemic lupus erythematosus. Gao N; Li MT; Li YH; Zhang SH; Dai RP; Zhang SZ; Zhao LD; Wang L; Zhang FC; Zhao Y; Zeng XF Lupus; 2017 Oct; 26(11):1182-1189. PubMed ID: 28355986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]